Influence of Maternal Breast Milk and Vaginal Microbiome on Neonatal Gut Microbiome: a Longitudinal Study during the First Year

Autor: Chandrika Bhattacharyya, Diganta Barman, Devashish Tripathi, Soumita Dutta, Chandra Bhattacharya, Mahabub Alam, Parveena Choudhury, Utpala Devi, Jagadish Mahanta, Reeta Rasaily, Analabha Basu, Suman K. Paine

Publikováno v: Microbiology Spectrum, Vol 11, Iss 3 (2023)

ABSTRACT It is believed that establishment of the gut microbiome starts very early in life and is crucial for growth, immunity, and long-term metabolic health. In this longitudinal study, we recruited 25 mothers in their third trimester, of whom 15 h

Externí odkaz: https://doaj.org/article/fe8b9643bf2048c490b41535f8ada8d4

Real-World Experience of Immunotherapy from India in Recurrent Squamous Cell Carcinoma of Head and Neck Cancer

Autor: Promila Pankaj, Pratik Patil, Swati Popli, Ranga R. Rao, Vineeta Goel, Saurabh Gupta, Devashish Tripathi, Waseem Abbas

Publikováno v: South Asian Journal of Cancer, Vol 10, Iss 02, Pp 72-75 (2021)

Background Recurrent metastatic head and neck squamous cell carcinoma (HNSCC) patients carry a poor prognosis and have limited therapeutic options. In the randomized phase-3 trial CheckMate 141, nivolumab showed benefit in overall survival (OS) with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e4bf2aeb479d2ed7ef5831378b371fc
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1729443

Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance

Autor: Suman Kalyan Paine, Usha Kiran Rout, Chandrika Bhattacharyya, Debaprasad Parai, Mahabub Alam, Rasmi Ranjan Nanda, Devashish Tripathi, Parveena Choudhury, Chanakya Nath Kundu, Sanghamitra Pati, Debdutta Bhattacharya, Analabha Basu

Publikováno v: NPJ biofilms and microbiomes. 8(1)

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has posed multiple challenges to global public health. Clinical features and sequela of SARS-CoV-2 infection include long-term and short-term complications often clinically ind

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32f98b545594fc264ff5a774a98887e3
https://pubmed.ncbi.nlm.nih.gov/36002454

Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy

Autor: Harm van Tinteren, Kate Haslett, Astrid Keijser, Annija van der Leest, Egbert F. Smit, Bart Reymen, Matthew Hatton, Suresh Senan, Iris E. van Dam, Jos A. Stigt, Ben J. Slotman, J. Knegjens, Corinne Faivre-Finn, Devashish Tripathi, J. Praag

Publikováno v: Lung Cancer, 108, 150-153. ELSEVIER IRELAND LTD
Lung Cancer, 108, 150-153. Elsevier Ireland Ltd
Slotman, B J, Faivre-Finn, C, van Tinteren, H, Keijser, A, Praag, J, Knegjens, J, Hatton, M, van Dam, I, van der Leest, A, Reymen, B, Stigt, J, Haslett, K, Tripathi, D, Smit, E F & Senan, S 2017, ' Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy : A secondary analysis of the Phase III CREST trial ', Lung Cancer, vol. 108, pp. 150-153 . https://doi.org/10.1016/j.lungcan.2017.03.007
Slotman, B J, Faivre-Finn, C, van Tinteren, H, Keijser, A, Praag, J O, Knegjens, J, Hatton, M, van Dam, I, van der Leest, A, Reymen, B, Stigt, J A, Haslett, K, Tripathi, D, Smit, E F & Senan, S 2017, ' Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy : A secondary analysis of the Phase III CREST trial ', Lung Cancer, vol. 108, pp. 150–153 . https://doi.org/10.1016/j.lungcan.2017.03.007

Introduction: In ES-SCLC patients with residual intrathoracic disease after first-line chemotherapy, the addition of thoracic radiotherapy reduces the risk of intrathoracic recurrence, and improves 2-year survival. To identify patient subgroups for f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::322dbaafe60a7267b7e96cab79b0469c
http://www.scopus.com/inward/record.url?scp=85016770261&partnerID=8YFLogxK